Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGLS Regulus Therapeutics Inc

交易中 12-23 13:57:09 EST

1.51

-0.08

-5.03%

最高1.59	最低1.49	成交量25.00万
今开1.57	昨收1.59	日振幅6.29%
总市值9,891万	流通市值7,348万	总股本6,550万
成交额38.12万	换手率0.51%	流通股本4,866万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGLS","market":"US","secType":"STK","nameCN":"Regulus Therapeutics Inc","latestPrice":1.51,"timestamp":1734980040607,"preClose":1.59,"halted":0,"volume":250032,"delay":0,"floatShares":48662433,"shares":65500134,"eps":-0.92479,"marketStatus":"交易中","marketStatusCode":2,"change":-0.08,"latestTime":"12-23 13:57:09 EST","open":1.57,"high":1.59,"low":1.49,"amount":381163.657704,"amplitude":0.062893,"askPrice":1.51,"askSize":646,"bidPrice":1.5,"bidSize":700,"shortable":3,"etf":0,"ttmEps":-0.92479,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"listingDate":1349323200000,"adjPreClose":1.59,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.5901,"preClose":1.59,"latestTime":"09:22 EST","volume":360,"amount":572.549544,"timestamp":1734963752844},"postHourTrading":{"tag":"盘后","latestPrice":1.59,"preClose":1.59,"latestTime":"18:43 EST","volume":48390,"amount":76940.42,"timestamp":1734738209031},"volumeRatio":1.070149,"impliedVol":0.7599,"impliedVolPercentile":0.0797},"requestUrl":"/m/hq/s/RGLS","defaultTab":"news","newsList":[{"id":"2493576469","title":"Regulus Therapeutics Inc.盘中异动 早盘急速下跌5.66%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493576469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493576469?lang=zh_cn&edition=full","pubTime":"2024-12-23 23:32","pubTimestamp":1734967959,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日23时32分，Regulus Therapeutics Inc.股票出现异动，股价快速下挫5.66%。截至发稿，该股报1.50美元/股，成交量2.2393万股，换手率0.03%，振幅4.40%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为791.08%、737.70%、653.20%，振幅较大的相关个股有Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.，振幅分别为157.37%、104.19%、96.28%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223233239ab8e5e2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223233239ab8e5e2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"gpt_icon":0},{"id":"2492260171","title":"Regulus Therapeutics Inc.盘中异动 股价大涨9.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492260171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492260171?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:35","pubTimestamp":1734618917,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时35分，Regulus Therapeutics Inc.股票出现异动，股价大幅上涨9.27%。截至发稿，该股报1.65美元/股，成交量3197股，换手率0.00%，振幅0.00%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为2.38%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922352095ea7abe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922352095ea7abe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RGLS"],"gpt_icon":0},{"id":"2492155872","title":"Regulus Therapeutics Inc.盘中异动 股价大跌5.56%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492155872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492155872?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:57","pubTimestamp":1734551862,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时57分，Regulus Therapeutics Inc.股票出现波动，股价快速下跌5.56%。截至发稿，该股报1.53美元/股，成交量9.3843万股，换手率0.14%，振幅6.17%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.88%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035742a1f9494c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035742a1f9494c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0},{"id":"2491372180","title":"Regulus Therapeutics Inc.盘中异动 大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491372180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491372180?lang=zh_cn&edition=full","pubTime":"2024-12-14 00:12","pubTimestamp":1734106346,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日00时12分，Regulus Therapeutics Inc.股票出现波动，股价快速跳水5.00%。截至发稿，该股报1.52美元/股，成交量5.6103万股，换手率0.09%，振幅7.81%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214001227ab75bae6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214001227ab75bae6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0},{"id":"2490914588","title":"Regulus Therapeutics Inc.盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490914588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490914588?lang=zh_cn&edition=full","pubTime":"2024-12-12 02:51","pubTimestamp":1733943106,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日02时51分，Regulus Therapeutics Inc.股票出现异动，股价急速拉升5.18%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Candel Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为453.53%、273.85%、123.09%，振幅较大的相关个股有Candel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为183.73%、149.24%、127.38%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212025146984b5fdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212025146984b5fdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","LENZ"],"gpt_icon":0},{"id":"2490010015","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490010015","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490010015?lang=zh_cn&edition=full","pubTime":"2024-12-11 00:14","pubTimestamp":1733847262,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日00时14分，Regulus Therapeutics Inc.股票出现异动，股价快速上涨5.70%。截至发稿，该股报1.66美元/股，成交量4.079万股，换手率0.06%，振幅3.86%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.14%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121100142295e8b37a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121100142295e8b37a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","LENZ"],"gpt_icon":0},{"id":"2489378822","title":"Regulus Therapeutics Inc.盘中异动 急速拉升6.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489378822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489378822?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:47","pubTimestamp":1733500068,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时47分，Regulus Therapeutics Inc.股票出现异动，股价大幅拉升6.62%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Adc Therapeutics Sa、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为59.47%、42.15%、29.95%，振幅较大的相关个股有Adc Therapeutics Sa、Tc Biopharm  Plc C/Wts 10/02/2028 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为40.01%、38.67%、36.94%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206234748a1d995a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206234748a1d995a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","LENZ"],"gpt_icon":0},{"id":"2489498080","title":"Regulus Therapeutics Inc.盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489498080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489498080?lang=zh_cn&edition=full","pubTime":"2024-12-06 01:35","pubTimestamp":1733420105,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日01时35分，Regulus Therapeutics Inc.股票出现波动，股价快速下挫5.28%。截至发稿，该股报1.53美元/股，成交量7.8385万股，换手率0.12%，振幅6.07%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120601350598e5a613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120601350598e5a613&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"gpt_icon":0},{"id":"2487565654","title":"Regulus Therapeutics Inc.盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487565654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487565654?lang=zh_cn&edition=full","pubTime":"2024-11-29 23:19","pubTimestamp":1732893550,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日23时19分，Regulus Therapeutics Inc.股票出现波动，股价大幅跳水5.18%。截至发稿，该股报1.56美元/股，成交量7.3862万股，换手率0.11%，振幅3.35%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112923191098e4688f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112923191098e4688f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0},{"id":"2485218114","title":"Regulus Therapeutics Inc.盘中异动 股价大涨5.00%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485218114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485218114?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:59","pubTimestamp":1732301958,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日02时59分，Regulus Therapeutics Inc.股票出现波动，股价快速上涨5.00%。截至发稿，该股报1.47美元/股，成交量16.4735万股，换手率0.25%，振幅6.79%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123025918abd7fd2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123025918abd7fd2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RGLS"],"gpt_icon":0},{"id":"2485411416","title":"Regulus Therapeutics Inc.盘中异动 早盘快速跳水6.07%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485411416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485411416?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:05","pubTimestamp":1732205152,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日00时05分，Regulus Therapeutics Inc.股票出现异动，股价大幅下跌6.07%。截至发稿，该股报1.32美元/股，成交量5.7704万股，换手率0.09%，振幅2.50%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112200055298e43f77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112200055298e43f77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"gpt_icon":0},{"id":"2483130601","title":"Regulus Therapeutics Inc.2024财年第三财季实现净利润-14.06百万美元，同比减少79.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483130601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483130601?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686435,"startTime":"0","endTime":"0","summary":"11月16日，Regulus Therapeutics Inc.公布财报，公告显示公司2024财年第三财季净利润为-14.06百万美元，同比减少79.80%；其中营业收入为0.00美元，每股基本收益为-0.21美元。从资产负债表来看，Regulus Therapeutics Inc.总负债6.96百万美元，其中短期债务764000.00美元，资产负债比为13.48，流动比率为13.66。机构评级：截至2024年11月16日，当前有6家机构对Regulus Therapeutics Inc.目标价做出预测，其中目标均价为10.33美元，其中最低目标价为3.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000316abc51604&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000316abc51604&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ"],"gpt_icon":0},{"id":"2483060433","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.33%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483060433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483060433?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:55","pubTimestamp":1731686122,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时55分，Regulus Therapeutics Inc.股票出现异动，股价急速跳水5.33%。截至发稿，该股报1.42美元/股，成交量9.0578万股，换手率0.14%，振幅6.00%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为3.55%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235522971a6e81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235522971a6e81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","LENZ"],"gpt_icon":0},{"id":"2482573452","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.44%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482573452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482573452?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:48","pubTimestamp":1731340113,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日23时48分，Regulus Therapeutics Inc.股票出现异动，股价大幅跳水5.44%。截至发稿，该股报1.39美元/股，成交量13.8238万股，换手率0.21%，振幅6.12%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111234833971a5c1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111234833971a5c1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2481161719","title":"Regulus Therapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481161719","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481161719?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:19","pubTimestamp":1731032394,"startTime":"0","endTime":"0","summary":"Regulus Therapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要Regulus Therapeutics Inc RGLS.OQ报告，截至9月30日的季度调整后每股亏损21美分，高于去年同期的每股-40美分。六位分析师对该季度的平均预期是每股亏损 17 美分。Regulus Therapeutics Inc 报告的季度每股收益为亏损 21 美分。该公司当季亏损 1406 万美元。Regulus Therapeutics Inc 本季度股价下跌了 3.8%，今年迄今为止上涨了 18.0%。华尔街对 Regulus Therapeutics Inc 的 12 个月目标价中位数为 7.50 美元。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF07P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGLS"],"gpt_icon":0},{"id":"2481988383","title":"Regulus Therapeutics Inc  预计每股亏损 17 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481988383","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481988383?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903558,"startTime":"0","endTime":"0","summary":"Regulus Therapeutics Inc  预计每股亏损 17 美分 - 财报前瞻Regulus Therapeutics Inc RGLS.OQ RGLS.O预计在11月7日公布截至2024年9月30日的财报时，季度营收将不会有任何变化(预计) LSEG分析师对Regulus Therapeutics Inc的平均预期为每股亏损17美分。华尔街对 Regulus Therapeutics Inc 的 12 个月目标价中位数为 7.50 美元，高于上一次收盘价 1.49 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4T3MD2M3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGLS"],"gpt_icon":0},{"id":"2479863031","title":"Regulus Therapeutics Inc.盘中异动 快速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479863031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479863031?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:47","pubTimestamp":1730386027,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时47分，Regulus Therapeutics Inc.股票出现异动，股价急速下跌5.13%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为3.55%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Mimedx Group, Inc、Celularity Inc C/Wts 16/07/2026 涨幅较大，Aditxt, Inc.、Evogene Ltd.、Palisade Bio, Inc.较为活跃，换手率分别为241.65%、230.15%、162.34%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Cingulate Inc C/Wts 10/12/2026 、Vaccinex, Inc.，振幅分别为46.15%、39.30%、37.72%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031224707ab8bed57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031224707ab8bed57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"gpt_icon":0},{"id":"2478438275","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨6.60%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478438275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478438275?lang=zh_cn&edition=full","pubTime":"2024-10-28 23:18","pubTimestamp":1730128698,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日23时18分，Regulus Therapeutics Inc.股票出现异动，股价急速上涨6.60%。截至发稿，该股报1.54美元/股，成交量16.4311万股，换手率0.25%，振幅4.86%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823181898e3ede9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823181898e3ede9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"gpt_icon":0},{"id":"2477559681","title":"Regulus Therapeutics Inc.盘中异动 股价大跌5.03%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477559681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477559681?lang=zh_cn&edition=full","pubTime":"2024-10-24 00:48","pubTimestamp":1729702105,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日00时48分，Regulus Therapeutics Inc.股票出现异动，股价急速下跌5.03%。截至发稿，该股报1.42美元/股，成交量8.6915万股，换手率0.13%，振幅5.03%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.07%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102400482598e3e0ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102400482598e3e0ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","LENZ"],"gpt_icon":0},{"id":"2476056943","title":"Regulus Therapeutics Inc.盘中异动 股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476056943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476056943?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:59","pubTimestamp":1729094391,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时59分，Regulus Therapeutics Inc.股票出现波动，股价快速拉升5.29%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，180 Life Sciences Corp.、Quoin Pharmaceuticals Ltd、Korro Bio, Inc.涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为6335.91%、1099.23%、939.89%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Quoin Pharmaceuticals Ltd，振幅分别为633.55%、279.52%、196.43%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016235952a1e123af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016235952a1e123af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regulusrx.com","stockEarnings":[{"period":"1week","weight":0.0063},{"period":"1month","weight":0.1357},{"period":"3month","weight":-0.1264},{"period":"6month","weight":-0.3665},{"period":"1year","weight":0.2823},{"period":"ytd","weight":0.2422}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Regulus Therapeutics Inc.于2007年9月6日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，致力于发现和开发针对microRNA的一流药物，以治疗具有重大医疗需求的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":-0.016722},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.00374},{"month":3,"riseRate":0.5,"avgChangeRate":0.090028},{"month":4,"riseRate":0.25,"avgChangeRate":-0.057759},{"month":5,"riseRate":0.583333,"avgChangeRate":0.084394},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.119338},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.130856},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.042258},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.004778},{"month":10,"riseRate":0.166667,"avgChangeRate":0.026008},{"month":11,"riseRate":0.461538,"avgChangeRate":0.057414},{"month":12,"riseRate":0.384615,"avgChangeRate":0.05046}],"exchange":"NASDAQ","name":"Regulus Therapeutics Inc","nameEN":"Regulus Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Regulus Therapeutics Inc,RGLS,Regulus Therapeutics Inc股票,Regulus Therapeutics Inc股票老虎,Regulus Therapeutics Inc股票老虎国际,Regulus Therapeutics Inc行情,Regulus Therapeutics Inc股票行情,Regulus Therapeutics Inc股价,Regulus Therapeutics Inc股市,Regulus Therapeutics Inc股票价格,Regulus Therapeutics Inc股票交易,Regulus Therapeutics Inc股票购买,Regulus Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}